Event Details

Join us at the 4^th TCR-based Therapies for Solid Tumors Summit in Boston as the must-attend forum for TCR experts to come together to share industry updates and next generation engineered approaches to boost therapy safety and efficacy.

Tuesday, April 4, 3:45 PM

• Session: Differentiating TCR Therapy Modalities to Identify & Harness their Unique Advantages
• Presentation: Advancing Development of TCR-T Cell Therapy Alongside TCR Bispecifics Modalities
• Speaker: Claudia Wagner, VP TCR Research, Immatics

Wednesday, April 5, 9:00 AM

• Session: Addressing Clinical Challenges to Accelerate the Route to Commercialization
• Presentation: Leveraging Biomarkers for Patient Stratification in Clinical Trials & Beyond
• Speaker: Andrea Mahr, Director Companion Diagnostics, Immatics

We are looking forward to meeting you!

For more information visit the event's homepage.